Governance and Corruption in the
Pharmaceutical Sector:
Causes and Consequences

I. Introduction

 9:00 - 9:05 am Welcome and Purpose of Workshop Jillian Kohler,
Erica Di Ruggiero

University of Toronto
 9:05 - 10:00 am Defining and Measuring Corruption and its Impact Manuel Balan
McGill University

 

II. Pharmaceutical Sector Topics

 10:00 - 10:30 am Vulnerabilities of the Pharmaceutical Sector to Corruption Jillian Kohler
University of Toronto
 10:30 - 11:00 am The Value and Limits of Pharmaceutical Transparency Trudo Lemmens
University of Toronto
 11:00 am - 12:00 pm Canada's Regulatory System and Governance Failures Joel Lexchin
York University
 12:00 - 12:45 pm Lunch  
 12:45 - 1:30 pm Incentivizing Company Performance in Fighting 
Corruption: The Access to Medicine Index
Danny Edwards
Access to Medicines 
Foundation
 1:30 - 2:15 pm The Role and Limits of Ethical Codes for the 
Pharmaceutical Industry
Carl Coleman
Seton Hall University
 2:15 - 3:00 pm Tackling Corruption in Healthcare Procurement: 
How 'Open Contracting' Improved Healthcare in 
Nigeria, Ukraine and Honduras
Lucas Amin
Transparency International
 3:00 - 3:45 pm Leveraging the Sustainable Development Goals to
Tackle Pharmaceutical Corrpution
Tim Mackey
University of California,
San Diego

 

III. Group Work and Discussion

 3:45 - 5:00 pm Group Work: Case Studies Kathy Moscou
University of Toronto 
 5:00 pm Conclusions Jillian Kohler
University of Toronto